Search research articles
Contact Us
Filters
Showing results (51-60 of 228) with videos related to
Page
of 23
Sort By:
Neurology
|
October 1, 1994
Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey
H Brønnum-Hansen, N Koch-Henriksen, K Hyllested
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 1984
Ia antigens and associated invariant chain are induced simultaneously in lines of T-dependent mast cells by recombinant interferon-gamma
N Koch, G H Wong, J W Schrader
Immunology
|
February 1, 1995
Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens
C Henne, F Schwenk, N Koch, et al.
Transplantation
|
August 1, 1983
Comparison of allogeneic and xenogeneic determinants on the H-2Kk molecule
S Koch, N Koch, P Robinson, et al.
AIDS (London, England)
|
March 10, 2001
Mutations in HIV-1 gag cleavage sites and their association with protease mutations
N Koch, N Yahi, J Fantini, et al.
Psychotherapy and Psychosomatics
|
March 1, 1996
Risk factors for suicide in multiple sclerosis
E N Stenager, N Koch-Henriksen, E Stenager
The EMBO Journal
|
June 1, 1987
Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii). An alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin
N Koch, W Lauer, J Habicht, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 17, 1998
Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry
N Koch-Henriksen, H Brønnum-Hansen, E Stenager
Neuroepidemiology
|
January 1, 1992
Incidence of multiple sclerosis in Denmark 1948-1982: a descriptive nationwide study
N Koch-Henriksen, H Brønnum-Hansen, K Hyllested
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 6, 2007
Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis?
P S Sorensen, N Koch-Henriksen, K Bendtzen
Page
of 23
Search research articles
Search
Showing results (51-60 of 228) with videos related to
Sort By:
Page
of 23
Neurology
|
October 1, 1994
Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey
H Brønnum-Hansen, N Koch-Henriksen, K Hyllested
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 1984
Ia antigens and associated invariant chain are induced simultaneously in lines of T-dependent mast cells by recombinant interferon-gamma
N Koch, G H Wong, J W Schrader
Immunology
|
February 1, 1995
Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens
C Henne, F Schwenk, N Koch, et al.
Transplantation
|
August 1, 1983
Comparison of allogeneic and xenogeneic determinants on the H-2Kk molecule
S Koch, N Koch, P Robinson, et al.
AIDS (London, England)
|
March 10, 2001
Mutations in HIV-1 gag cleavage sites and their association with protease mutations
N Koch, N Yahi, J Fantini, et al.
Psychotherapy and Psychosomatics
|
March 1, 1996
Risk factors for suicide in multiple sclerosis
E N Stenager, N Koch-Henriksen, E Stenager
The EMBO Journal
|
June 1, 1987
Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii). An alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin
N Koch, W Lauer, J Habicht, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 17, 1998
Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry
N Koch-Henriksen, H Brønnum-Hansen, E Stenager
Neuroepidemiology
|
January 1, 1992
Incidence of multiple sclerosis in Denmark 1948-1982: a descriptive nationwide study
N Koch-Henriksen, H Brønnum-Hansen, K Hyllested
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 6, 2007
Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis?
P S Sorensen, N Koch-Henriksen, K Bendtzen
Page
of 23